Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Sim

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Rheumatic Diseases|July 27, 2021
Self-concept and body image of people living with lupus: A systematic reviewLarissa Rodrigues, Maria M F Sim-Sim, Luis Sousa, et al.
British Journal of Pharmacology|July 1, 1992
Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failureC L Perreault, N L Hague, E Loh, et al.
Journal of Cardiovascular Pharmacology|May 1, 1994
Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failureR E Weishaar, A M Wallace, L M Kiser, et al.
European Journal of Pharmacology|June 4, 1993
Relationship between inotropic activity and phosphodiesterase inhibition for flosequinan and milrinoneR E Weishaar, M L Kirker, A M Wallace, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Rheumatic Diseases|July 27, 2021
Self-concept and body image of people living with lupus: A systematic reviewLarissa Rodrigues, Maria M F Sim-Sim, Luis Sousa, et al.
British Journal of Pharmacology|July 1, 1992
Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failureC L Perreault, N L Hague, E Loh, et al.
Journal of Cardiovascular Pharmacology|May 1, 1994
Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failureR E Weishaar, A M Wallace, L M Kiser, et al.
European Journal of Pharmacology|June 4, 1993
Relationship between inotropic activity and phosphodiesterase inhibition for flosequinan and milrinoneR E Weishaar, M L Kirker, A M Wallace, et al.
Pageof 2